September 8, 2022

Janssen Pharmaceuticals, Inc.: Expert Perspectives on the Treatment of DVT/PE nd Reduction in the Risk of Recurrent DVT/PE, with a Focus on DVT/PE Patients with Obesity and/or Cancer

Tuesday, October 10
11:30 am – 12:15 pm
Location: Expert Theater 1


James Neuenschwander MD, FACEP, FASAM; W. Frank Peacock, MD, FACEP, FACC, FESC; and James Williams, MS, DO, FACEP

Theater Information

Distinguished faculty will provide expert perspectives on the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and reduction in the risk of recurrent DVT and/or PE. In addition, they will discuss the treatment of and reduction in the risk of recurrent DVT/PE in patients with obesity and/or cancer.

September 29 - October 2

You've Built a Life in Emergency Medicine

Reconnect with friends from every chapter of your career at ACEP24

Register TodayBook Hotel

[ Feedback → ]